143 related articles for article (PubMed ID: 33420361)
21. Cancer cell-associated cytoplasmic B7-H4 is induced by hypoxia through hypoxia-inducible factor-1α and promotes cancer cell proliferation.
Jeon YK; Park SG; Choi IW; Lee SW; Lee SM; Choi I
Biochem Biophys Res Commun; 2015 Apr; 459(2):277-283. PubMed ID: 25725157
[TBL] [Abstract][Full Text] [Related]
22. A Key role for cyclic AMP-responsive element binding protein in hypoxia-mediated activation of the angiogenesis factor CCN1 (CYR61) in Tumor cells.
Meyuhas R; Pikarsky E; Tavor E; Klar A; Abramovitch R; Hochman J; Lago TG; Honigman A
Mol Cancer Res; 2008 Sep; 6(9):1397-409. PubMed ID: 18819928
[TBL] [Abstract][Full Text] [Related]
23. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
Ezponda T; Popovic R; Shah MY; Martinez-Garcia E; Zheng Y; Min DJ; Will C; Neri A; Kelleher NL; Yu J; Licht JD
Oncogene; 2013 Jun; 32(23):2882-90. PubMed ID: 22797064
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition.
Yamazaki H; Lai YC; Tateno M; Setoguchi A; Goto-Koshino Y; Endo Y; Nakaichi M; Tsujimoto H; Miura N
PLoS One; 2017; 12(5):e0177305. PubMed ID: 28489881
[TBL] [Abstract][Full Text] [Related]
25. Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
Fulciniti M; Tassone P; Hideshima T; Vallet S; Nanjappa P; Ettenberg SA; Shen Z; Patel N; Tai YT; Chauhan D; Mitsiades C; Prabhala R; Raje N; Anderson KC; Stover DR; Munshi NC
Blood; 2009 Jul; 114(2):371-9. PubMed ID: 19417213
[TBL] [Abstract][Full Text] [Related]
26. Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug.
Hu J; Handisides DR; Van Valckenborgh E; De Raeve H; Menu E; Vande Broek I; Liu Q; Sun JD; Van Camp B; Hart CP; Vanderkerken K
Blood; 2010 Sep; 116(9):1524-7. PubMed ID: 20530289
[TBL] [Abstract][Full Text] [Related]
27. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.
Kuo AJ; Cheung P; Chen K; Zee BM; Kioi M; Lauring J; Xi Y; Park BH; Shi X; Garcia BA; Li W; Gozani O
Mol Cell; 2011 Nov; 44(4):609-20. PubMed ID: 22099308
[TBL] [Abstract][Full Text] [Related]
28. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
Lauring J; Abukhdeir AM; Konishi H; Garay JP; Gustin JP; Wang Q; Arceci RJ; Matsui W; Park BH
Blood; 2008 Jan; 111(2):856-64. PubMed ID: 17942756
[TBL] [Abstract][Full Text] [Related]
29. HIF-1α inhibits Wnt signaling pathway by activating Sost expression in osteoblasts.
Chen D; Li Y; Zhou Z; Wu C; Xing Y; Zou X; Tian W; Zhang C
PLoS One; 2013; 8(6):e65940. PubMed ID: 23776575
[TBL] [Abstract][Full Text] [Related]
30. The expression of Wnt-inhibitor DKK1 (Dickkopf 1) is determined by intercellular crosstalk and hypoxia in human malignant gliomas.
Guo KT; Fu P; Juerchott K; Motaln H; Selbig J; Lah T; Tonn JC; Schichor C
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1261-70. PubMed ID: 24770633
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.
Keats JJ; Maxwell CA; Taylor BJ; Hendzel MJ; Chesi M; Bergsagel PL; Larratt LM; Mant MJ; Reiman T; Belch AR; Pilarski LM
Blood; 2005 May; 105(10):4060-9. PubMed ID: 15677557
[TBL] [Abstract][Full Text] [Related]
32. SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic
Chong PSY; Chooi JY; Lim JSL; Toh SHM; Tan TZ; Chng WJ
Cancer Res; 2021 May; 81(9):2332-2344. PubMed ID: 33602783
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia and vitamin D differently contribute to leptin and dickkopf-related protein 2 production in human osteoarthritic subchondral bone osteoblasts.
Bouvard B; Abed E; Yéléhé-Okouma M; Bianchi A; Mainard D; Netter P; Jouzeau JY; Lajeunesse D; Reboul P
Arthritis Res Ther; 2014 Oct; 16(5):459. PubMed ID: 25312721
[TBL] [Abstract][Full Text] [Related]
34. Anticancer efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in osteolytic breast cancer murine models.
Liapis V; Zinonos I; Labrinidis A; Hay S; Ponomarev V; Panagopoulos V; Zysk A; DeNichilo M; Ingman W; Atkins GJ; Findlay DM; Zannettino AC; Evdokiou A
Cancer Med; 2016 Mar; 5(3):534-45. PubMed ID: 26749324
[TBL] [Abstract][Full Text] [Related]
35. Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase.
Liu Q; Geng H; Xue C; Beer TM; Qian DZ
Biochim Biophys Acta; 2015 May; 1853(5):881-91. PubMed ID: 25637186
[TBL] [Abstract][Full Text] [Related]
36. MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomib.
Xie Z; Bi C; Chooi JY; Chan ZL; Mustafa N; Chng WJ
Leukemia; 2015 Dec; 29(12):2347-54. PubMed ID: 26196464
[TBL] [Abstract][Full Text] [Related]
37. The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.
Marango J; Shimoyama M; Nishio H; Meyer JA; Min DJ; Sirulnik A; Martinez-Martinez Y; Chesi M; Bergsagel PL; Zhou MM; Waxman S; Leibovitch BA; Walsh MJ; Licht JD
Blood; 2008 Mar; 111(6):3145-54. PubMed ID: 18156491
[TBL] [Abstract][Full Text] [Related]
38. Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
Hudlebusch HR; Theilgaard-Mönch K; Lodahl M; Johnsen HE; Rasmussen T
Br J Haematol; 2005 Sep; 130(5):700-8. PubMed ID: 16115125
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.
Fowler JA; Mundy GR; Lwin ST; Edwards CM
Cancer Res; 2012 May; 72(9):2183-9. PubMed ID: 22374979
[TBL] [Abstract][Full Text] [Related]
40. Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease.
Kristensen IB; Christensen JH; Lyng MB; Møller MB; Pedersen L; Rasmussen LM; Ditzel HJ; Abildgaard N
Leuk Lymphoma; 2014 Apr; 55(4):911-9. PubMed ID: 23915193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
